This Government Contract opportunity from Department Of Health And Human Services was posted on July 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Notice of Intent to Sole Source Flea-Borne Typhus

Closed

97543Federal

Submission Closed08/06/2026, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621511

New

SLED

Comprehensive Drug Screening and Laboratory AnalysisThis subcontract for Comprehensive Drug Screening and Laboratory Analysis involves providing clinical collection and laboratory analysis of biological samples for prime contractors on ALEA drug screening projects. The scope of work includes conducting hair analysis and Non-NIDA Panel 8 testing, utilizing specialized clinical laboratory equipment and strict Chain of Custody forms to ensure accuracy and compliance. Beyond technical analysis, the provider is responsible for the medical review of non-negative results and the delivery of confirmed drug screen reports. The contract also encompasses the management of centralized billing and administrative functions to support the overall drug screening operation for the Alabama Personnel agency.

POSTED

DEADLINE

Personnel- ALEA Drug Screening

Solicitation # SRC0000037283

This solicitation, identified as SRC0000037283, is for the provision of a comprehensive drug testing and screening program for the Alabama Law Enforcement Agency (ALEA). The scope of work includes the administration of various drug screens, such as hair analysis via LabCorp PSC, non-NIDA panel 8 tests, and saliva testing, along with the provision of test kits. Additionally, the contractor is responsible for providing a two-hour online reasonable suspicion training session compliant with DOT and Drug Free Workplace regulations, managing random selection processes, and performing medical reviews of non-negative results. The contract is processed as a Quick Quote through the Alabama Buys system, with the State of Alabama reserving the right to evaluate bids based on cost realism and price reasonableness. The resulting contract may be renewed annually for a total period of up to five years, with a total cost cap of 25,000 dollars. Key compliance requirements include mandatory enrollment in E-Verify for suppliers with employees in Alabama, registration with the Alabama Secretary of State for foreign entities, and strict adherence to state tax certifications under Section 41-4-142 of the Code of Alabama 1975. Legal venue for any disputes is established in the City of Montgomery, Alabama. Suppliers must submit all responses electronically via the Alabama Buys portal and may be required to provide professional licenses, certificates of insurance, and manufacturer authorizations following the bid opening.

POSTED

DEADLINE

Accredited DNA Testing ProviderThis subcontract for the City and County of Swansea requires an accredited DNA testing provider to support safeguarding and social care projects. The selected provider will be responsible for the end-to-end testing process, including identity verification, the collection of buccal swab samples, and strict chain of custody management. Technical requirements include performing DNA profiling and comparison within accredited sequencing laboratories to ensure the highest standards of accuracy. Beyond laboratory analysis, the provider must deliver formal verified reports and provide expert witness testimony for court hearings. This opportunity was posted on October 20, 2026, with a response deadline of November 16, 2026. The services fall under NAICS code 621511, focusing on specialized medical diagnostic services to support legal and social care outcomes.

City & County of Swansea

POSTED

DEADLINE

Accredited Drug and Alcohol Testing ProviderThis subcontract agreement establishes an Accredited Drug and Alcohol Testing Provider to support prime contractors on statutory projects for the City and County of Swansea. The selected provider is responsible for the end-to-end testing process, including field or clinic-based sample collection, the management of a secure chain of custody to ensure legal admissibility, and comprehensive laboratory analysis. To maintain these standards, the provider must utilize accredited laboratory facilities and secure transport containers. Beyond technical testing, the provider is required to deliver professional test reports and offer expert interpretation of results. This scope of work extends to legal support, requiring the provider to furnish expert witness testimony during legal proceedings. Interested parties must respond by November 16, 2026, in accordance with the solicitation posted on October 20, 2026.

City & County of Swansea

POSTED

DEADLINE

Framework Agreement for DNA, Drug and Alcohol Testing Services

Solicitation # CCS/26/257

The City and County of Swansea is establishing a Framework Agreement under solicitation CCS/26/257 for accredited testing services to support statutory functions, including social care, safeguarding, and legal proceedings. The framework is divided into two lots: Lot 1 for Drug and Alcohol Testing Services and Lot 2 for DNA Testing Services, with each lot having an estimated value of 350,000 GBP excluding VAT. The scope of work includes identity verification for DNA testing and expert witness support where required. The agreement is scheduled to run from January 11, 2027, to January 10, 2032, with an option to extend for an additional 24 months through January 10, 2034. A maximum of six suppliers may be appointed to the framework, and the council may award contracts through either direct award or mini-competition. This procurement is designated as a light touch regime and is open to small and medium-sized enterprises as well as voluntary, community, and social enterprises. Interested parties must submit their tenders electronically via the eTenderWales portal by November 16, 2026, at 12:00pm. Submissions are accepted in both English and Welsh, and bidders may apply for one or both available lots.

City & County of Swansea

POSTED

DEADLINE

STAT Clinical Laboratory Testing & AnalysisThis subcontract for STAT Clinical Laboratory Testing and Analysis supports prime contractors on Department of Veterans Affairs healthcare system projects. The selected provider will perform 24/7/365 analysis and monitoring of patient specimens, ensuring immediate notification of critical results and the delivery of final written reports within five working days. To qualify, the provider must employ board-certified pathologists and maintain a NYS DOH Clinical Laboratory Permit and a CLIA license. Additionally, the facility must hold accreditation from either the College of American Pathologists or the Joint Commission. This opportunity is categorized under NAICS code 621511 and is managed by the Department of Veterans Affairs Network Contract Office 02.

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Q301--FY27 (BASE+4) STAT Laboratory Testing - Syracuse (VA-27-00010334)

Solicitation # 36C24227Q0069

The Department of Veterans Affairs VISN 2 Network Contracting Office intends to award a firm fixed-price contract for STAT laboratory testing services at the Syracuse VA Medical Center. The proposed contract structure includes a base period followed by four option periods. The government intends to sole source this requirement to University Pathologists Laboratories under FAR 6.302-1(a)(2), though this special notice serves as market research to identify other capable providers, including various small business socioeconomic categories. The scope of work involves the 24/7, 365-day-a-year analysis, monitoring, and reporting of clinical and surgical specimens, utilizing advanced methods such as electron microscopy and molecular studies. Key operational requirements include picking up specimens within 30 minutes of a request and delivering final written reports within five working days. Critical results require immediate notification to authorized providers. To be eligible, the contractor must employ board-certified pathologists and accredited technologists and maintain mandatory certifications, including a NYS Department of Health Clinical Laboratory Permit, a CLIA license, and CAP or Joint Commission accreditation. This acquisition falls under NAICS code 621511. Interested parties must provide documentation of their technical expertise and socioeconomic status to the contracting officer within 10 calendar days of the notice publication.

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Specialized Cell Source & Biobank SupplyThis subcontract opportunity with the National Institutes of Health, under the Department of Health and Human Services, focuses on the supply and qualification of human cell sources and biological resources for prime contractors working on NIAID infectious disease projects. The selected provider will be responsible for sourcing, characterizing, and qualifying primary cells or human cell lines that represent diverse human variability, utilizing genomic characterization tools and cryogenic storage to ensure quality and stability. The scope of work includes performing essential qualification of cell sources as a project benchmark and delivering fully characterized tissue samples or cell lines. Interested parties should note that the response deadline is January 29, 2027, and the project falls under NAICS code 621511.

National Institutes Of Health

POSTED

DEADLINE

Forensic Toxicology Laboratory ServicesThis subcontract for Forensic Toxicology Laboratory Services supports Florida Department of Transportation drug testing projects by providing professional analysis of collected drug and alcohol specimens for prime contractors. The selected provider is responsible for analyzing specimens for controlled substances, processing split samples, and delivering all test results and reports to the Medical Review Officer. To qualify, the provider must operate a certified forensic toxicology laboratory that adheres to all USDOT and FMCSA standards. This opportunity falls under NAICS code 621511, with a response deadline set for November 4, 2026.

Florida Department of Transportation

POSTED

DEADLINE

Controlled Substances and Alcohol Use Testing

Solicitation # DOT-RFP-27-9020-JM

The Florida Department of Transportation is soliciting competitive proposals under solicitation number DOT-RFP-27-9020-JM for third-party controlled substances and alcohol use testing program management services. The selected vendor will be responsible for administering testing for CDL drivers and other department employees, including random selection and testing using scientifically valid methods, providing Substance Abuse Professional services for rehabilitation monitoring, and maintaining 24-hour emergency collection coordination. The scope of work requires strict adherence to federal regulations, including USDOT 49 CFR Part 40 and FMCSA 49 CFR Part 382, as well as the Florida Drug-Free Workplace Act. Deliverables include a secure, password-protected website for results and statistical reporting, with monthly itemized invoicing submitted through the MyFloridaMarketplace system. The procurement process requires a two-part submission consisting of a technical proposal and a price proposal. To be considered responsive, proposers must achieve a minimum average score of 70 points on the technical evaluation, which is weighted across a management plan, work plan, executive summary, and technical plan. The contract is planned for performance across multiple fiscal years from 2027 through 2031. Eligible bidders must be registered in MyFloridaMarketplace, authorized to do business in Florida, and compliant with scrutinized companies lists and non-discrimination statutes. Evaluation is based on the grand total of tests, fees, and services, and the department reserves the right to conduct on-site reviews of facilities and qualifications prior to contract execution.

Florida Department of Transportation

POSTED

DEADLINE

Referral Laboratory ServicesThis subcontract for Referral Laboratory Services supports prime contractors on Department of Veterans Affairs projects under Network Contracting Office 6. The scope of work involves performing referral laboratory testing and diagnostic services, utilizing electronic systems for the ordering and reporting of results. To ensure clinical quality and data security, the provider must maintain CLIA certification and CMS-deemed status through either the College of American Pathologists or The Joint Commission. Additionally, strict adherence to HIPAA regulations is required for the handling of all patient data. The contract is categorized under NAICS code 621511.

246-NETWORK Contracting Office 6 (36C246)

POSTED

DEADLINE

Karius Liquid Biopsy / Cell-Free DNA Testing ServicesThis subcontract involves the provision of specialized diagnostic testing services for prime contractors supporting the Department of Veterans Affairs Caribbean Healthcare System in San Juan. The scope of work focuses on the processing of clinical specimens using Karius-specific liquid biopsy protocols and the analysis of cell-free DNA to identify infectious agents. To qualify, the service provider must utilize the Karius testing platform technology and maintain current CLIA certification. The contract emphasizes strict adherence to HIPAA compliance to ensure the secure electronic transmission of sensitive patient data. Deliverables include the provision of secure electronic test results and detailed diagnostic reports. This opportunity is categorized under NAICS code 621511 and is managed by the Department of Veterans Affairs Network Contract Office 8.

248-NETWORK Contract Office 8 (36C248)

POSTED

3 days ago

DEADLINE

in 1 day

AI Contract Overview

The Centers for Disease Control and Prevention plans to award a sole source firm fixed price contract to Quest Diagnostics for the provision of serum clinical specimens collected from routine patient testing, along with associated remanent services including selection, de-identification, and shipment of these specimens to CDC. These specimens are valued for their unique geographic, sex, and age metadata tied to patients in Georgia, particularly at the zip code level, information not available from any other source. This geographic precision is essential for a serological survey targeting flea-borne typhus, as it allows for accurate spatial analysis and targeted public health intervention. Quest Diagnostics is the only vendor capable of providing this level of location detail, making competition unfeasible under current requirements. This procurement is authorized under FAR 6.103-1 (SAP) and 41 U.S.C. 1901, permitting non-competitive acquisition due to the absence of alternative sources with comparable data capabilities. While not a formal solicitation, the government is inviting any interested parties to submit responses within fifteen days of the notice issuance to assess potential competition, though the decision to proceed without competition rests solely with the government. All responses must be emailed to contract specialist Iris Gonzalez at qsx8@cdc.gov no later than August 6, 2026, at 5:00 p.m. EST. The contract falls under NAICS code 621511, with performance centered in Atlanta, Georgia, and is managed by the CDC Office of Acquisition Services under the Department of Health and Human Services.

General Info

CDC awards Quest Diagnostics sole source contract for geolocated serum specimens to study flea-borne typhus in Georgia.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition Services

NAICS

621511 - Medical Laboratories

Place of Performance

Atlanta, GA, 30341, USA

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedJul 22

special-notice

Response DeadlineAug 6

Deadline has passed

Submission Closed

08/06/2026, 09:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services

Contacts1 person available

OfficeATLANTA, GA, 30333, USA

Organization / AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services

Office AddressATLANTA, GA, 30333, USA

Contacts

Iris Gonzalez

contact@example.gov

Full Description

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order/contract to Quest Diagnostics. for Serum Clinical specimens from routine clinical testing. Remanent services: select, de-identify, and ship specimens to CDC. Serum specimens provided through Quest Diagnostics comprise a unique sample of clinical specimens from patients having blood drawn for routine laboratory testing. Quest Diagnostics has access to geographic details for Georgia along with sex and age information, which is not provided through other sources. It is critical to the study to obtain information for specific geographic areas in Georgia. Quest Diagnostics was the only vendor that could provide precise locations of place of residency for the patients. Program could not identify other sources with similar geographic information at the zip code level. Serum specimens provided through Quest Diagnostics also contain information on sex and age, which may provide information beneficial for the proposed serological survey.

This contract action is for supplies/services for which the Government intends to solicit and negotiate with only one source under the authority of Revolutionary FAR Overhaul 6.103-1 (SAP) ; under the authority of 41 U.S.C. 1901, as implemented in FAR subpart 12.102. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email qsx8@cdc.gov by August 6, 2026 before 5pm EST.